P

Inventor

CHEN XIAOQI

US52 patents
⚠️ This page may combine multiple inventors who share the name “CHEN XIAOQI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

AMGEN INC

27 patents
US6835726B2Dec 28, 2004

Pyrimidine derivatives

AMGEN INC99 citations97
US10221162B2Mar 5, 2019

Triazole agonists of the APJ receptor

AMGEN INC12 citations92
US10058550B2Aug 28, 2018

Methods of treating heart failure

AMGEN INC13 citations92
US9868721B2Jan 16, 2018

Triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9845310B2Dec 19, 2017

Intermediates for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9751864B2Sep 5, 2017

Methods for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9745286B2Aug 29, 2017

Triazole agonists of the APJ receptor

AMGEN INC16 citations92
US9656998B2May 23, 2017

Intermediates for preparing triazole agonists of the APJ receptor

AMGEN INC14 citations92
US9656997B2May 23, 2017

Triazole agonists of the APJ receptor

AMGEN INC16 citations92
US9573936B2Feb 21, 2017

Triazole agonists of the APJ receptor

AMGEN INC19 citations92
US7045527B2May 16, 2006

Piperidine derivatives

AMGEN INC39 citations92
US7148259B1Dec 12, 2006

Antibacterial agents

AMGEN INC23 citations91
US7799795B2Sep 21, 2010

Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders

AMGEN INC21 citations90
US10150760B2Dec 11, 2018

Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor

AMGEN INC8 citations84
US9988369B2Jun 5, 2018

Heterocyclic triazole compounds as agonists of the APJ receptor

AMGEN INC8 citations83
US9593129B2Mar 14, 2017

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC5 citations83
US9296736B2Mar 29, 2016

Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer

AMGEN INC7 citations83
US7939538B2May 10, 2011

Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases

AMGEN INC20 citations83
US9376425B2Jun 28, 2016

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

AMGEN INC12 citations82
US11046680B1Jun 29, 2021

Heteroaryl-substituted triazoles as APJ receptor agonists

AMGEN INC2 citations62
US10736883B2Aug 11, 2020

Triazole furan compounds as agonists of the APJ receptor

AMGEN INC1 citations62
US7572783B2Aug 11, 2009

Substituted benzofused heterocycles

AMGEN INC3 citations61
US7053234B2May 30, 2006

Antibacterial agents

AMGEN INC2 citations61
US6858619B2Feb 22, 2005

Fused heterocyclic compounds

AMGEN INC3 citations59
US7253179B2Aug 7, 2007

Fused heterocyclic compounds

AMGEN INC1 citations51
US9359355B2Jun 7, 2016

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

AMGEN INC0 citations49
US7125885B2Oct 24, 2006

Fused heterocyclic compounds

AMGEN INC0 citations49

ABBOTT LAB

6 patents

TULARIK INC

4 patents

AT & T IP I LP

3 patents

AMGEN SF LLC

2 patents

BEIJING XUANYI PHARMASCIENCES CO LTD

2 patents

CHEN XIAOQI

1 patent

WOOD ALAN RUTHVEN

1 patent

QINGDAO KINGAGROOT RESISTANT WEED MAN CO LTD

1 patent

INVERT ROBOTICS LTD

1 patent

UNIV NANJING POSTS & TELECOMMUNICATIONS

1 patent

UNIV SHANDONG

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.